Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul;29(4):224-8.
doi: 10.1097/YIC.0000000000000021.

Pharmacotherapy in the treatment of patients with borderline personality disorder: results of a survey among psychiatrists in private practices

Moritz Knappich  1 , Susanne Hörz-Sagstetter, Dirk Schwerthöffer, Stefan Leucht, Michael Rentrop
Affiliations

Pharmacotherapy in the treatment of patients with borderline personality disorder: results of a survey among psychiatrists in private practices

Moritz Knappich et al. Int Clin Psychopharmacol. 2014 Jul.

Abstract

Pharmacotherapy still seems to play a major role in the treatment of patients suffering from borderline personality disorder (BPD). However, little is known about psychiatrists' detailed perspective on indication and significance of medication. A total of 233 psychiatrists in the city of Munich and in Upper Bavaria were asked by questionnaire about their treatment habits in the medical treatment of patients with BPD. One hundred and forty-one psychiatrists answered the questionnaire (60.5%). In total, 94% of BPD patients were treated with psychotropic medication. Psychiatrists predominantly saw an indication to prescribe antidepressants (98%), followed by antipsychotics, mood stabilizers, and benzodiazepines. Citalopram/escitalopram and quetiapine were mentioned most frequently. The results are discussed in conjunction with the international guidelines for the treatment of BPD.

PubMed Disclaimer

References

    1. Abraham PF, Calabrese JR.Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?J Affect Disord 2008;111:21–30 - PubMed
    1. APA Practice guidelines for the treatment of patients with borderline personality disorder 2001Washington, DC, USA:APA
    1. Bohus M.Borderline-Störung 2002Göttingen:Hogrefe
    1. Feurino L, Silk KR.State of the art in the pharmacologic treatment of borderline personality disorder.Curr Psychiatry Res 2011;13:69–75 - PubMed
    1. Filipetto FA, zipp CP, Coren JS.Potential for pregabalin abuse or diversion after past drug-seeking behavior.J Am Osteopath Assoc 2010;110:605–607 - PubMed

MeSH terms